Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in primary pterygium
NCT01380678Phase 3Unknown
- Sponsor
- Khon Kaen University
- Start
- Jan 2009
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bevacizumab in pterygium, sponsored by Khon Kaen University. Primary endpoint: Percentage of corneal pterygium area at 3 years. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT01380678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01380678.